Marijt E A, Veenhof W F, Goulmy E, Kluck P M, Brand A, Willemze R, van Rood J J, Falkenburg J H
Department of Hematology, University Medical Center, Leiden, The Netherlands.
Hum Immunol. 1993 Aug;37(4):221-8. doi: 10.1016/0198-8859(93)90505-u.
A patient with acute leukemia and her family including four HLA-identical siblings were analyzed to select a donor who was not only HLA- but also minor histocompatibility (mH) antigen compatible for allogeneic bone marrow transplantation (BMT). The HLA-A2 restricted mH antigen-specific HA-1, -2, -4, and -5 cytotoxic T-lymphocyte (CTL) clones were used to type the family members for expression of these mH antigens. The patient and one HLA-identical sibling were compatible for these mH antigens. This sibling was selected as the bone marrow donor. The patient engrafted promptly but developed acute and chronic graft-versus-host disease. To study the presence of other mH antigen disparities between recipient and donor, host-versus-graft CTL lines and clones were generated by stimulation of recipient peripheral blood lymphocytes (PBLs) with donor bone marrow cells, and graft-versus-host CTL lines were generated after BMT by stimulation of PBLs of donor origin with recipient bone marrow cells. These CTL lines were cytotoxic to cells from the bone marrow donor and from the recipient, respectively, and to cells from several other family members. T-cell lines, generated from the patient after BMT by stimulation of recipient-derived PBLs with donor bone marrow cells, exhibited no specific cytotoxicity to donor or recipient cells. Chimerism studies after BMT revealed that the PBLs and T-cell lines generated after BMT were of donor origin.(ABSTRACT TRUNCATED AT 250 WORDS)
对一名急性白血病患者及其包括四名HLA匹配同胞的家庭成员进行分析,以选择一名不仅HLA匹配,而且次要组织相容性(mH)抗原也与异基因骨髓移植(BMT)相匹配的供体。使用HLA-A2限制性mH抗原特异性HA-1、-2、-4和-5细胞毒性T淋巴细胞(CTL)克隆对家庭成员进行这些mH抗原表达的分型。患者和一名HLA匹配的同胞在这些mH抗原上相匹配。这名同胞被选为骨髓供体。患者移植迅速,但发生了急性和慢性移植物抗宿主病。为了研究受体和供体之间是否存在其他mH抗原差异,通过用供体骨髓细胞刺激受体外周血淋巴细胞(PBL)产生宿主抗移植物CTL系和克隆,并在BMT后通过用受体骨髓细胞刺激供体来源的PBL产生移植物抗宿主CTL系。这些CTL系分别对来自骨髓供体、受体以及其他几名家庭成员的细胞具有细胞毒性。BMT后通过用供体骨髓细胞刺激受体来源的PBL从患者产生的T细胞系对供体或受体细胞没有特异性细胞毒性。BMT后的嵌合研究表明,BMT后产生的PBL和T细胞系来自供体。(摘要截断于250字)